-
1
-
-
33947429261
-
Considerations in the rational design and conduct of phase I/II pediatric clinical trials: Avoiding the problems and pitfalls
-
[Review]
-
Abdel-Rahman SM, Reed MD, Wells TG, Kearns GL Considerations in the rational design and conduct of phase I/II pediatric clinical trials: avoiding the problems and pitfalls. [Review]. Clin Pharmacol Ther 2007; 81: 483-94.
-
(2007)
Clin Pharmacol Ther
, vol.81
, pp. 483-494
-
-
Abdel-Rahman, S.M.1
Reed, M.D.2
Wells, T.G.3
Kearns, G.L.4
-
2
-
-
0036138407
-
Pediatric clinical trials: Shall we take a lead?
-
[comment]
-
Schreiner MS, Greeley WJ Pediatric clinical trials: Shall we take a lead? [comment]. Anesth Analg 2002; 94: 1-3.
-
(2002)
Anesth Analg
, vol.94
, pp. 1-3
-
-
Schreiner, M.S.1
Greeley, W.J.2
-
4
-
-
70449728484
-
Bridging studies
-
In Chow SC. (ed.). Marcel Dekker, New York
-
Liu JP Bridging studies. In Chow SC. (ed.). Encyclopedia of Biopharmaceutical Statistcs, Marcel Dekker, New York, 2003, pp. 134-38.
-
(2003)
Encyclopedia of Biopharmaceutical Statistcs
, pp. 134-138
-
-
Liu, J.P.1
-
5
-
-
0036428684
-
Bayesian approach to evaluation of bridging studies
-
Liu JP, Hsiao CF, Hsueh H. Bayesian approach to evaluation of bridging studies. J Biopharm Stat 2002; 12: 401 - 08.
-
(2002)
J Biopharm Stat
, vol.12
, pp. 401-408
-
-
Liu, J.P.1
Hsiao, C.F.2
Hsueh, H.3
-
6
-
-
0026014245
-
Bayesian subset analysis
-
Dixon DO, Simon R. Bayesian subset analysis. Biometrics 1991; 47: 871-81.
-
(1991)
Biometrics
, vol.47
, pp. 871-881
-
-
Dixon, D.O.1
Simon, R.2
-
8
-
-
24944463173
-
A Bayesian approaches to randomized controlled trials in children utilizing information from adults: The case of Guillain-Barre syndrome
-
Goodman SN, Sladky JT A Bayesian approaches to randomized controlled trials in children utilizing information from adults: The case of Guillain-Barre syndrome. Clin Trials 2005; 2: 305-10.
-
(2005)
Clin Trials
, vol.2
, pp. 305-310
-
-
Goodman, S.N.1
Sladky, J.T.2
-
9
-
-
0028798488
-
Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care
-
Lau J., Schmid CH, Chalmers TC Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care. J Clin Epidemiol 1995; 48: 45-57.
-
(1995)
J Clin Epidemiol
, vol.48
, pp. 45-57
-
-
Lau, J.1
Schmid, C.H.2
Chalmers, T.C.3
-
10
-
-
0029898186
-
Meta-analysis in the design and monitoring of clinical trials
-
DerSimonian R. Meta-analysis in the design and monitoring of clinical trials. Stat Med 1996; 15: 1237-48.
-
(1996)
Stat Med
, vol.15
, pp. 1237-1248
-
-
DerSimonian, R.1
-
11
-
-
0002083004
-
Power prior distributions for regression models
-
Ibrahim JG, Chen MH Power prior distributions for regression models. Stat Sci 2000; 15: 46-60.
-
(2000)
Stat Sci
, vol.15
, pp. 46-60
-
-
Ibrahim, J.G.1
Chen, M.H.2
-
12
-
-
67649376266
-
The reltaionship between the power prior and hierarchical models
-
Chen MH, Ibrahim JG The reltaionship between the power prior and hierarchical models. Bayesian Anal 2006; 1: 551-74.
-
(2006)
Bayesian Anal
, vol.1
, pp. 551-574
-
-
Chen, M.H.1
Ibrahim, J.G.2
-
13
-
-
84928772798
-
-
Available at: (accessed 26 May)
-
The BUGS project. Available at: http://www.mrcbsu.cam.ac.uk/bugs/winbugs/ contents.shtml (accessed 26 May 2009)
-
(2009)
The BUGS Project
-
-
-
14
-
-
0030664978
-
Large sample Bayesian inference on the parameters of the proportional hazard models
-
Faraggi D., Simon RM Large sample Bayesian inference on the parameters of the proportional hazard models. Stat Med 1997; 16: 2573-85.
-
(1997)
Stat Med
, vol.16
, pp. 2573-2585
-
-
Faraggi, D.1
Simon, R.M.2
-
15
-
-
0034021941
-
Approximate Bayesian evaluation of multiple treatment effects
-
Thall PF, Simon RM, Shen Y. Approximate Bayesian evaluation of multiple treatment effects. Biometrics 2000; 56: 213-9.
-
(2000)
Biometrics
, vol.56
, pp. 213-219
-
-
Thall, P.F.1
Simon, R.M.2
Shen, Y.3
-
18
-
-
0036345669
-
Statistical evaluation of ventilator free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome
-
Schoenfeld DA, Bernard GR Statistical evaluation of ventilator free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002; 30: 1772-7.
-
(2002)
Crit Care Med
, vol.30
, pp. 1772-1777
-
-
Schoenfeld, D.A.1
Bernard, G.R.2
-
19
-
-
0035826096
-
Efficacy and safety of recombinant human activated protein C for severe sepsis?
-
Bernard GR, Vincent J-L., Laterre P-F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis? N Engl J Med 2001; 344: 699-709.
-
(2001)
N Engl J Med
, vol.344
, pp. 699-709
-
-
Bernard, G.R.1
Vincent, J.-L.2
Laterre, P.-F.3
-
21
-
-
0033051086
-
Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans
-
Schwartz JI, Chan C. -C, Mukhopadhyay S., et al. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans. Clin Pharmacol Ther 1999; 65: 653-60.
-
(1999)
Clin Pharmacol Ther
, vol.65
, pp. 653-660
-
-
Schwartz, J.I.1
Chan, C.-C.2
Mukhopadhyay, S.3
-
22
-
-
24344474345
-
Aspirin compared with acetaminophen in the treatment of feverand other symptoms of upper respiratory tract infection in adults: A multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study
-
Bachert C., Chuchalin AG, Eisebitt R., et al. Aspirin compared with acetaminophen in the treatment of feverand other symptoms of upper respiratory tract infection in adults: A multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study. Clin Ther 2005; 27: 993-1003.
-
(2005)
Clin Ther
, vol.27
, pp. 993-1003
-
-
Bachert, C.1
Chuchalin, A.G.2
Eisebitt, R.3
-
23
-
-
0030734342
-
Equivalent antipyretic activity of ibuprofen and paracetamol in febrile children
-
Vauzelle-Kervroedan F., d'Athis P., Pariente-Khayat A., et al. Equivalent antipyretic activity of ibuprofen and paracetamol in febrile children. J Pediatr 1997; 131: 683-7.
-
(1997)
J Pediatr
, vol.131
, pp. 683-687
-
-
Vauzelle-Kervroedan, F.1
d'Athis, P.2
Pariente-Khayat, A.3
|